366 related articles for article (PubMed ID: 26095468)
21. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
Picard C; Lega JC; Ranchin B; Cochat P; Cabrera N; Fabien N; Belot A
Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
[TBL] [Abstract][Full Text] [Related]
22. Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis.
Chen DY; Hsieh CW; Chen KS; Chen YM; Lin FJ; Lan JL
Lupus; 2009 Jan; 18(1):29-37. PubMed ID: 19074166
[TBL] [Abstract][Full Text] [Related]
23. Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients.
Jesus AA; Campos LM; Liphaus BL; Carneiro-Sampaio M; Mangueira CL; Rosseto EA; Silva CA; Scheinberg M
Rev Bras Reumatol; 2012 Dec; 52(6):976-81. PubMed ID: 23223707
[TBL] [Abstract][Full Text] [Related]
24. GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosus.
Mosaad YM; Hammad A; Elghzaly AA; Tawhid ZME; Hammad EM; Showma A; Abdelsalam R; Elmoughy A; Fawzy IM; Anber N
Lupus; 2018 Nov; 27(13):2112-2119. PubMed ID: 30301440
[TBL] [Abstract][Full Text] [Related]
25. Association of Tumor Necrosis Factor Alpha-Induced Protein 3 Interacting Protein 1 (TNIP1) Gene Polymorphism (rs7708392) with Lupus Nephritis in Egyptian Patients.
Rizk MM; Elsayed ET; ElKeraie AF; Ramzy I
Biochem Genet; 2018 Oct; 56(5):478-488. PubMed ID: 29589214
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
27. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.
Zhang CQ; Ren L; Gao F; Mu FY; You YQ; Liu YH
Clin Rheumatol; 2011 Jul; 30(7):967-73. PubMed ID: 21340499
[TBL] [Abstract][Full Text] [Related]
28. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
[TBL] [Abstract][Full Text] [Related]
29. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
[TBL] [Abstract][Full Text] [Related]
30. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
31. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
[TBL] [Abstract][Full Text] [Related]
32. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
[TBL] [Abstract][Full Text] [Related]
33. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
34. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
Pang Y; Tan Y; Li Y; Zhang J; Guo Y; Guo Z; Zhang C; Yu F; Zhao MH
Kidney Int; 2016 Dec; 90(6):1357-1367. PubMed ID: 27745701
[TBL] [Abstract][Full Text] [Related]
35. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
Badr AMM; Farag Y; Abdelshafy M; Riad NM
Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
[TBL] [Abstract][Full Text] [Related]
36. Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis.
de Liso F; Matinato C; Novembrino C; Radice A; Raffiotta F; Ronchi M; Croci MD; Sinico RA; Messa P; Torresani E; Moroni G
Clin Chem Lab Med; 2015 Oct; 53(11):1771-7. PubMed ID: 25870967
[TBL] [Abstract][Full Text] [Related]
37. Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis.
Norsworthy P; Theodoridis E; Botto M; Athanassiou P; Beynon H; Gordon C; Isenberg D; Walport MJ; Davies KA
Arthritis Rheum; 1999 Sep; 42(9):1828-32. PubMed ID: 10513796
[TBL] [Abstract][Full Text] [Related]
38. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
Tsanyan ME; Torgashina AV; Aleksandrova EN; Soloviev SK; Nasonov EL
Ter Arkh; 2013; 85(5):53-9. PubMed ID: 23819340
[TBL] [Abstract][Full Text] [Related]
39. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
ElGendi SS; El-Sherif WT
Egypt J Immunol; 2009; 16(1):135-48. PubMed ID: 20726330
[TBL] [Abstract][Full Text] [Related]
40. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
